{"entities":{"Q9898":{"pageid":14059,"ns":120,"title":"Item:Q9898","lastrevid":205816,"modified":"2020-05-21T15:47:42Z","type":"item","id":"Q9898","labels":{"en":{"language":"en","value":"Sakamuri D, et al. Mol. Cancer Ther. (2018) cited as Ref 635 in DOI: 10.1038/s41392-020-0110-5"}},"descriptions":{"en":{"language":"en","value":"Cited in: \"Targeting cancer stem cell pathways for cancer therapy\" in Signal Transduct Target Ther; 2020 ; 5 8"}},"aliases":[],"claims":{"P17":[{"mainsnak":{"snaktype":"value","property":"P17","datavalue":{"value":{"entity-type":"item","numeric-id":7916,"id":"Q7916"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9898$7FFA7ABC-37CD-42D6-8B5C-FE1707F8C967","rank":"normal"}],"P94":[{"mainsnak":{"snaktype":"value","property":"P94","datavalue":{"value":{"entity-type":"item","numeric-id":8449,"id":"Q8449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9898$CC769266-EE42-48CD-A579-03AE47C8DC8D","rank":"normal"}],"P149":[{"mainsnak":{"snaktype":"value","property":"P149","datavalue":{"value":"Sakamuri D","type":"string"},"datatype":"string"},"type":"statement","id":"Q9898$8C3A1941-ED3B-47A9-9F55-9CE8E05175F4","rank":"normal"}],"P138":[{"mainsnak":{"snaktype":"value","property":"P138","datavalue":{"value":"10.1158/1535-7163.MCT-17-0673","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9898$5444F2C4-A86A-46A8-A723-6D991FF290B4","rank":"normal"}],"P140":[{"mainsnak":{"snaktype":"value","property":"P140","datavalue":{"value":"29237802","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9898$1A1B4E9C-4B71-4D0E-9BA4-44A9B7C64775","rank":"normal"}],"P100":[{"mainsnak":{"snaktype":"value","property":"P100","datavalue":{"value":{"time":"+2018-01-01T00:00:00Z","timezone":0,"before":0,"after":0,"precision":9,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q9898$FB4C616F-7017-45EB-84DE-C18EA6ABFE1E","rank":"normal"}],"P102":[{"mainsnak":{"snaktype":"value","property":"P102","datavalue":{"value":"Mol. Cancer Ther.","type":"string"},"datatype":"string"},"type":"statement","id":"Q9898$F0A106FB-2FA8-41BA-9B53-09C3B1858609","rank":"normal"}],"P103":[{"mainsnak":{"snaktype":"value","property":"P103","datavalue":{"value":"17","type":"string"},"datatype":"string"},"type":"statement","id":"Q9898$7CAD8FBA-7F71-4C67-8405-0F43021FB09F","rank":"normal"}],"P93":[{"mainsnak":{"snaktype":"value","property":"P93","datavalue":{"value":{"text":"Phase I dose-escalation study of anti-CTLA-4 antibody ipilimumab and lenalidomide in patients with advanced cancers","language":"en"},"type":"monolingualtext"},"datatype":"monolingualtext"},"type":"statement","id":"Q9898$0224D51F-6279-4839-9032-B6EB016AFD5E","rank":"normal"}],"P105":[{"mainsnak":{"snaktype":"value","property":"P105","datavalue":{"value":"671-676","type":"string"},"datatype":"string"},"type":"statement","id":"Q9898$7C9C4073-E491-480D-84E2-DAEA3F9AC2CA","rank":"normal"}]},"sitelinks":{"sliswiki":{"site":"sliswiki","title":"Sakamuri D, et al. Mol. Cancer Ther. (2018) cited as Ref 635 in DOI: 10.1038/s41392-020-0110-5","badges":[],"url":"https://wikibase.slis.ua.edu/wiki/Sakamuri_D,_et_al._Mol._Cancer_Ther._(2018)_cited_as_Ref_635_in_DOI:_10.1038/s41392-020-0110-5"}}}}}